Compass Pathways (CMPS) announced its common stock will be added to the Nasdaq Biotechnology Index effective prior to market open on Monday, December 23.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CMPS:
- Rising High: Organigram acquires Motif Labs for C$90M upfront
- Rising High: Cannabis firms report quarterly earnings
- Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
- Atai Life Sciences price target lowered to $10 from $15 at H.C. Wainwright
- Rising High: Exclusive talk with house of brands Carma HoldCo
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
